BackTWi Biotechnology Overview

TWi Biotechnology Long Term Debt

Latest long-term debt for 6610.TWO: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-1.59M vs prior year quarter

Peer trimmed avg / median

Loading

TWi Biotechnology Long Term Debt History

Loading

TWi Biotechnology vs. peers: Long Term Debt Comparison

Loading

TWi Biotechnology Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TWi Biotechnology (6610.TWO) FAQ

As of the most recent data (June 2026), 6610.TWO shows a long-term debt of $0. That compares with $1.6M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6610.TWO's long-term debt is now $0 (was $1.6M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether TWi Biotechnology is outperforming or lagging.

Tracking 6610.TWO's long-term debt over time shows whether TWi Biotechnology is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.6M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has TWi Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

TWi Biotechnology's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.